Full Judgment Text
Text read from the judgment PDF published on the High Court's eCourts portal, through the
Indian High Court Judgments open data set (Dattam Labs,
CC BY 4.0).
The court's own copy is the authoritative text.
*
IN THEHIGH COURTOF DELHIAT NEW DELHI
#
CNR No. DLHC010644832023
+
CS(COMM) 948/2023 & I.A. 26277/2023
GLAXOSMITHKLINE BIOLOGICALS SA
.....Plaintiff
Through: Mr. Vardaan Anand, Advocate.
Versus
HUMAN BIOLIFE INDIA PVT. LTD.& ORS
.....Defendants
Through: Mr. Subhash Chandra Sagar and Mr.
Abhivan D.K, Advocates for D-1.
Mr. Pranav Sapra, Advocate for D-2
and D-3.
CORAM:
HON’BLE MR. JUSTICE TEJAS KARIA
ORDER
%
13.10.2026
1.
Learned Counsel for the Parties submit that the Parties have entered
into a Settlement Agreement dated 24.04.2026 (“Settlement Agreement”)
and that the Suit may be decreed in terms of the Settlement Agreement, which
provides as under:
“1.
The Second Party hereby acknowledges and recognizes that
the First Party is the owner/proprietor of the below mentioned
trademarks as mentioned in the suit and undertakes not to challenge
the validity of the same before any court of law and/or forum:
S. No.
Trademark
Registration No.
Registration date
Class
1.
ENGERIX
421433
04/05/1984
2.
HAVRIX
638704
01/09/1994
3.
ENGERIX-B
648329
09/12/1994
4.
TRITANRIX
656030
17/02/1995
5.
HIBERIX
656493
22/02/1995
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
6.
TWINRIX
680441
18/09/1995
7.
INFANRIX
680452
18/09/1995
8.
PRIORIX
762435
21/07/1997
9.
TYPHERIX
798731
16/04/1998
10.
BOOSTRIX
823941
2/10/1998
11.
VARILRIX
830146
01/12/1998
12.
FLUARIX
832562
16/12/1998
13.
ROTARIX
870321
09/08/1999
14.
AMBIRIX
876478
15/09/1999
15.
CERVARIX
1066178
11/12/2001
16.
SYNFLORIX
1270517
03/03/2004
17.
RIX
1354194
28/04/2005
The aforementioned list of trademarks of the First Party are
collectively referred to as “First Party’s trademarks”.
2.
The Second Party agrees and undertakes to not adopt in the
future any trade mark similar to the First Party’s afore-mentioned
trade marks included in paragraph 1 of the instant settlement
agreement.
3.
The Second Party hereby undertakes not to use, make, sell,
offer for sale, advertise, any products or services, directly or
indirectly (whether online and / or offline) under the marks
‘RUTORIX’, ‘DROTARIX’, ‘AMIRIX’, .’CEFTARIX’, and ‘MIRIX’
and hereby represents that it has ceased all use, sale, offering for
sale, advertisement of such products (whether offline or online). The
Second Party further agrees to expressly withdraw and/or apply for
cancellation of all of its applications and registrations (by filing
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
requisite forms TM-M or TM-P as may be the case) for the marks
‘RUTORIX’, ‘DROTARIX’, ‘AMIRIX’, ‘CEFTARIX’, and ‘MIRIX’,
and any other deceptively similar variants of the same within 15 days
of execution of the present settlement agreement.
4.
In furtherance to the above, the Second Party undertakes to
recall all its products manufactured under the afore-mentioned marks
being circulated in the market and destroy the same within 15 days of
execution of the present agreement under proof to the First Party.
Further, the Second Party shall also take all reasonable steps to take
down all online and/or offline listings of the products marketed under
the afore-mentioned marks including on their own website and other
third-party platforms and provide to the counsel for Plaintiff details
of the existing or last batch of products under the impugned mark
such as batch nos. and manufacturing/ expiry dates of the respective
products within 15 days of execution of the present Settlement
Agreement.
5.
The Second Party agrees and undertakes not to use the
below-mentioned trade marks for vaccines and injectable
preparations and will continue to use these trade marks for other
pharmaceutical preparations such as tablets, capsules, syrups, oral
suspensions. The Second Party further agrees and undertakes to
apply for amendment of the ‘goods specifications’ section of its trade
mark applications/ registrations and add the exclusion which would
read as thus “all of the foregoing excluding vaccines and injectable
preparations”.
S. No.
Mark
Last Batch No. & date of expiry
Trade Mark Application
No.
1.
LYCORIXX
ALD5545D; 08/2027
3865499
2.
ETIZORIX
Discontinued
4584967
3.
OFZORIX
AKX01BUA; 05/2027
4584969
4.
DEFZORIX
LGP07/226/03; 06/2027
4764976
5.
KITRIX
XT3638C; 01/2027
5051289
6.
TOLPERIX
ADT252140A; 07/2027
6495930
7.
FLUCORIX
LGP05/073/02; 04/2027
N/A
8.
TREXORIX
LGP03/354J01; 02/2027
N/A
9.
CACCIRIX
AKX01BGA; 03/2027
N/A
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
6.
The Second Party agrees and undertakes to limit the use of the
marks PIPTARIX (trade mark registration no. 5393215), MERORIXX
(trade mark application no. 5393128), and ESOMRJX (trade mark
application no. 5393219) to the goods which are being offered under
the at-issue marks, i.e., injections used to treat bacterial infections.
The Second Party agrees and undertakes not to use the marks
PIPTARIX, MERORIXX or ESOMRIX for any other injectable
products besides injections used to treat bacterial infections. The
Second Party further agrees and undertakes to apply for amendment
of the ‘goods specifications’ section of its trade mark applications/
registrations to limit the goods claimed under these trade marks and
add the exclusion of vaccines which would read as thus “injections
used to treat bacterial infections; excluding vaccines”.
7.
Subject to the filing of the amendment for goods specifications
of the trade mark applications/ registrations and the same being
brought on record by the Trade Marks Registry, the First Party
agrees and undertakes to withdraw the opposition/ cancellation
proceedings filed against the respective trade mark applications/
registrations of the Second Party contained in paragraphs 3 and 5 of
the instant agreement.
8.
It is clarified that the Second Party is not restrained from
using the suffix ‘RIX’ as part of its future trade marks subject to the
following conditions (i) the Second Party shall not use or adopt any
future marks with the suffix RIX for vaccines or injectable
pharmaceutical products, and (ii) the Second Party shall not adopt a
trade mark confusingly similar to the First Party’s trade marks as
contained in paragraph 1. To avoid any future disputes inter se the
parties, a comprehensive list of First Party’s RIX formative trade
mark registrations is attached as ANNEXURE-C and Second Party
undertakes to not adopt any mark similar to any of the trade marks
contained in the said Annexure. Further, the Second Party agrees and
undertakes to exclude vaccines and injectable pharmaceuticals
products from the goods specifications section of all future trade
mark applications containing RIX, which exclusion shall read as thus
“all of the foregoing excluding vaccines and injectable
preparations”.
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
9.
The Second Party submits that it has, to the best of its
knowledge, taken down all online listings of products bearing the
Second Party’s trade marks being ‘RUTORIX’, ‘DROTARIX’,
‘AMIRIX’, ‘CEFTARIX’, ‘TREXORIX’, ‘CALCIRIX’, and ‘MIRIX’.
Out of abundant caution, the Second Party requests that in case any
residual listing on the internet is still active on its website or on any
other third party platform including E-Pharmacies and social media
platforms, the same may be reported by the First Party and the
Second Party undertakes to take all possible and reasonable steps to
initiate take-down action of the listing within 72 hours of the First
Party reporting the same.
10.
With a view to put a quietus to the disputes and amicably settle
the same, and provided Second Party is otherwise in compliance with
the terms and conditions of this Agreement, the First Party agrees not
to press for its claim for monetary claims as sought in terms of the
paragraphs 60 (c), (d), (e), and (f) of the Plaint. Each of the parties
agree to bear their own costs and fees associated with this dispute
and the Agreement.
11.
The Parties have agreed that, in accordance with the terms set
out in the Agreement, they shall pray to the Hon’ble Court that the
Commercial Suit seeking permanent injunction for trademark
infringement, passing off, damages, rendition of accounts, delivery
up, etc. being CS (COMM.) No. 948/2023 may be decreed by the
Hon’ble High Court of Delhi, in favour of the First Party and against
the Second Party, in terms of the prayers in Paragraph 60 (a) and (b)
of the Plaint provided that such permanent injunction as sought in the
above paragraphs shall not include the marks MERORIXX,
PIPTARIX and ESOMRIX.
12.
The Parties agree that the Prayer clause under paragraph 42
(f) of the Plaint relating to the grant of damages stands settled and
concluded in terms of clause 8 (above) of the present Agreement.
13.
The First Party is at liberty to pray before the Hon’ble Court
requesting for refund of the court fees to the First Party in terms of
Section 16 of the Court Fees Act, 1870 read with Section 89 of CPC,
1908 and Second Party has no objection to this request.
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
14.
The Parties agree that they have executed the present
Agreement by their free will and volition without any force or
pressure from anybody. The Parties also agree that they have
understood the contents of the present Agreement as the same have
been explained to them by the Mediator and their respective counsel,
in the presence of each other and they have consented to the same in
its true letter and spirit, and as such they shall not dispute the same in
the future.
15.
The Parties agree that they shall abide by the terms and
conditions set out in the present Agreement. The Parties further agree
that the statements made by them in this Agreement shall be taken as
their respective undertakings to the Hon’ble Court and the defaulting
party shall be held liable for contempt of court under the Contempt of
Courts Act, 1971. The First Party will also be at liberty to institute
fresh proceedings on any such further and fresh cause of action that
may arise against the Second Party in the future.
16.
That the Parties undertake that they are bound by this
Agreement and further undertake to abide by the terms and
conditions set out in this agreement and not to dispute the same in the
future.”
2.
Learned Counsel for the Plaintiff submits that with regard to Paragraph
No. 4 of the Settlement Agreement, instead of 15 days’ time stipulated
therein, time of two months may be granted from the date of this Order.
3.
Accordingly, the terms of Paragraph No. 4 of the Settlement
Agreement is modified to the extent that time of 15 days provided therein
stands modified to time of two months from today.
4.
Further, learned Counsel for the Plaintiff submits that following URLs
may be taken down pursuant to the Settlement Agreement agreed between the
Parties:
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
Marks
RUTORIX
ACTIVE LINKS
1. https://www.humanbiolife.com/rutorix-a-tablet
2. https://www.1mg.com/drugs/rutorix-tablet-723925?srsltid=Afm
BOortaQEtIrOkBsnQSrppovxQm_JaGzlBXDwvu2xTYggLeM7
pNYf0&wpsrc= Google+Organic+Search
3. https://company.pharmahopers.com/human-biolife-india-pvt-ltd/
product/rutorix-a-tablets
4. https://www.indiamart.com/proddetail/rutoriix-a-trypsin-bromela
in-rutoside-aceclofenac-tablets-2855829224833.html?srsltid=Af
mBOoqX2Pku-m72jrvgyrXLBAVmHhBaqLsDE4kgmfNfKgOw
Bgp1L_7e
5. https://www.apollopharmacy.in/medicine/rutorix-d-tab-10-s?srslt
id=AfmBOooKqacAPsMoKAPgfp71VeffLtSNN-c4rcsxn85qQF
7M3cuN1pu7
DROTARIX 1. https://www.humanbiolife.com/DROTARIX-SUSPENSION
2. https://www.humanbiolife.com/drotarix-40-tablet3. https://www.humanbiolife.com/drotarix-injectable
4. https://www.1mg.com/drugs/drotarix-m-80mg-250mg-tablet-510
440?srsltid=AfmBOoqgi7y4_ZhofFuDuxhote-yRIyz_hIbhJIhBU
diZlsrzN_27F75&wpsrc=Google+Organic+Search
5. https://www.1mg.com/drugs/drotarix-m-80mg-250mg-tablet-510
440?srsltid=AfmBOoqgi7y4_ZhofFuDuxhote-yRIyz_hIbhJIhBU
diZlsrzN_27F75&wpsrc=Google+Organic+Search
6. https://www.apollopharmacy.in/medicine/drotarix-a-80mg-100m
g-tablet?srsltid=AfmBOorGUakN6_59Tl0152DG01mH9Ct2Ovy
wsdwaua_mr_Jy8be90VCx
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
7. https://www.indiamart.com/proddetail/drotarix-m-drotaverine-hy
drochloride-mefenamic-acid-tablets-2855639807655.html?srsltid
=AfmBOoquFl0XycVQffompF5Mfba_GXC7M8BseMbsT5Yj2s
XeT0P0DBR
AMIRIX
1. https://www.humanbiolife.com/amirix-250-injectable
2. https://www.humanbiolife.com/amirix-100-injectable
3. https://www.humanbiolife.com/amirix-500-injectable
4. https://www.1mg.com/drugs/amirix-100mg-injection-510301?srs
ltid=AfmBOoooUb_bQMVeLfm
EmsLENpfiq15A3PbnbDY02P25iOcT1xW9asXe&wpsrc=Goog
le+Organic+Search
5. https://www.truemeds.in/medicine/amirix-100-mg-injection-1-tm
-inon2-010563
CEFTARIX
1. https://www.humanbiolife.com/ceftarix-1gm-injectable
2. https://www.humanbiolife.com/ceftarix-250-injectable
3. https://www.humanbiolife.com/ceftarix-tz-1125-injectable
4. https://www.1mg.com/drugs/ceftarix-250mg-injection-510351?sr
sltid=AfmBOoqMo0Odd2iiD3JHNZjcEt5-SWS6d87Y3Y5QQ4
HgJW3d14ZRaTqG&wpsrc=Google+Organic+Search
5. https://www.truemeds.in/medicine/ceftarix-250-mg-injection-1-t
m-inon2-013273
6. https://www.1mg.com/drugs/ceftarix-tz-1000mg-125mg-injectio
n-813880?srsltid=AfmBOooNDzXnQySolM1fdYLW-Dxbx16A
A0htbTNgnTu_4l-jrLrYcO0E&wpsrc=Google+Organic+Search
7. https://www.medibuddy.in/order-medicines/ceftarix-250mg-injec
tion-1000473416
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
5.
Learned Counsel for the Plaintiff is at liberty to communicate the said
URLs to the respective intermediaries, who are directed, upon receipt of a
copy of this Order, to take down the same within a period of one week.
6.
Learned Counsel for Defendant No. 2 submits that Defendant Nos. 2
and 3 have a limited role to play as Defendant Nos. 2 and 3 were the
manufacturers of Defendant No. 1. Accordingly, Defendant Nos. 2 and 3 shall
be bound by the terms of the Settlement Agreement to the extent it is
applicable to Defendant Nos. 2 and 3.
7.
Learned Counsel for the Plaintiff submits that the same direction may
also be passed against Defendant Nos. 4 and 5.
8.
Accordingly, Defendant Nos. 4 and 5 are also bound by the terms of the
Settlement Agreement to the extent it is applicable to Defendant Nos. 4 and 5.
9.
Let the Decree Sheet be drawn up accordingly. The Suit and pending
Applications stand disposed of in the terms aforesaid.
TEJAS KARIA, J
OCTOBER 13, 2026
ap
CS(COMM) 948/2023
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 15/10/2026 at 11:25:24
This page is for informational and research purposes only and does not constitute legal advice.
Consult a qualified advocate for advice specific to your situation.
Is your name in this judgment and should it be masked, or is something on this page wrong?
Request a review